| Issue | Title | |
| Vol 2, No 1 (2022) | A brief report of real-world evidence development (RWD/RWE) in 2021: United States, Russia, and the Eurasian Economic Union (EAEU) | Abstract PDF (Rus) PDF (Eng) |
| A. S. Kolbin, D. Yu. Belousov | ||
| Vol 5, No 2 (2025) | A systematic review with meta-analysis and indirect comparison of the results of studies evaluating the efficacy and safety of ceftobiprole and ceftaroline in adult patients in the treatment of infections of various localizations | Abstract PDF (Rus) |
| Yu. M. Gomon, A. S. Petrichenko | ||
| Vol 4, No 2 (2024) | Analysis of real-world data for medical device evaluation: Chinese manual | Abstract PDF (Rus) |
| A. R. Kasimova, Wenlong Zhao | ||
| Vol 2, No 3 (2022) | Analysis of RWD/RWE recommendations and guidelines for 2021. International experience on the example of USA | Abstract PDF (Rus) |
| A. Kurylev | ||
| Vol 3, No 3 (2023) | Analyzing FDA's approaches to using electronic health record and medical claims data to support regulatory decision making | Abstract PDF (Rus) |
| Ksenia S. Radaeva, M. V. Pchelintsev | ||
| Vol 1, No 1 (2021) | Applying real-world data to justify requirements to purchased drugs in public procurement | Abstract PDF (Rus) PDF (0,3 Mb) (Eng) |
| M. A. Borzova | ||
| Vol 4, No 4 (2024) | Approaches to resolve practical challenges in the context of assessing the price of biosimilar products | Abstract PDF (Rus) |
| A. H.-M. Valeeva, M. I. Baranova | ||
| Vol 5, No 1 (2025) | Aspects of pharmaceutical care for patients with cephalgia in specialized neurology clinics | Abstract PDF (Rus) |
| O. V. Reshetko, A. I. Grishin, R. R. Parsamyan, E. A. Rakhmanova | ||
| Vol 2, No 1 (2022) | Aspects of the safe use of medicinal products based on medicinal plant materials in COVID-19 | Abstract PDF (Rus) |
| A. A. Taube | ||
| Vol 3, No 1 (2023) | Assessing the risks of abuse of opioids in real-world data | Abstract PDF (Rus) |
| M. V. Pchelintsev | ||
| Vol 4, No 2 (2024) | Assessment of computer and statistical literacy levels among medical students | Abstract PDF (Rus) |
| N. Yu. Dmitrieva | ||
| Vol 4, No 4 (2024) | Assessment of quality of presentation of clinical trial results in Russia in accordance with CONSORT standards | Abstract PDF (Rus) |
| A. R. Kasimova, N. M. Guseinova | ||
| Vol 2, No 1 (2022) | Chinese experience on using RWE to support drug research, development and evaluation | Abstract PDF (Rus) |
| A. S. Kolbin, D. Yu. Belousov | ||
| Vol 2, No 2 (2022) | Combining real-world data with randomized controlled trials results in better information oncology decision making | Abstract PDF (Rus) |
| T. A. Usmanova, E. V. Verbitskaya | ||
| Vol 4, No 3 (2024) | Computerized systems and databases for pharmacovigilance in Russia | Abstract PDF (Rus) |
| B. K. Romanov, E. N. Saykina, E. Yu. Baidikova, U. M. Shirokova, E. D. Shchukin | ||
| Vol 3, No 4 (2023) | Considerations for the design and conduct of externally controlled trials for drug and biological products | Abstract PDF (Rus) |
| A. S. Motrinchuk, D. Yu. Belousov | ||
| Vol 4, No 1 (2024) | Current issues related to the off-label use of drugs and their potential solutions | Abstract PDF (Rus) |
| K. S. Radaeva, S. A. Mishinova | ||
| Vol 2, No 4 (2022) | DARWIN EU® is an electronic platform for the collection and analysis of health data in the European Union | Abstract PDF (Rus) |
| K. S. Radaeva, E. V. Verbitskaya | ||
| Vol 3, No 2 (2023) | Decentralized clinical trials: regulatory perspectives in Russia and the EAEU | Abstract PDF (Rus) |
| M. A. Borzova, S. V. Semina | ||
| Vol 3, No 2 (2023) | Drug utilization research at the individual level as the main concept of pharmacoepidemiology | Abstract PDF (Rus) |
| S. M. Mukhina, M. I. Baranova, Yu. M. Gomon | ||
| Vol 4, No 1 (2024) | Economics of diabetes mellitus type 2 control based on big data modeling | Abstract PDF (Rus) |
| S. V. Svetlichnaya, L. D. Popovich | ||
| Vol 4, No 4 (2024) | Educational pharmacoepidemiology and "Real-World Knowledge" | Abstract PDF (Rus) |
| R. A. Bontsevich | ||
| Vol 2, No 2 (2022) | Electronic medical records as a source of real-world clinical data | Abstract PDF (Rus) |
| A. V. Gusev, B. V. Zingerman, D. S. Tyufilin, V. V. Zinchenko | ||
| Vol 2, No 2 (2022) | Ethical review of real-world study | Abstract PDF (Rus) |
| E. A. Volskaya, A. L. Khokhlov, D. Yu. Belousov | ||
| 1 - 24 of 83 Items | 1 2 3 4 > >> | |
Browse Title Index
Popular articles
Vol 3, No 1 (2023)
Vol 3, No 2 (2023)
Vol 3, No 4 (2023)
Vol 4, No 1 (2024)
Vol 4, No 2 (2024)
Vol 4, No 3 (2024)
Keywords
COVID-19
EAEU
FDA
NICE
RWD
RWE
big data
clinical pharmacology
databases
guidance
health technology assessment
observation programs
pharmacovigilance
real-world clinical data
real-world clinical practice
real-world data
real-world evidence
recommendations
regulatory approaches
resolution
vaccination
